Navigation Links
Benign eye tumors being treated

Researchers at the University of Texas feel that they may have found an effective treatment for a type of non-cancerous eye tumor that threatens clear vision.// Using photodynamic therapy, researchers successfully restored vision in three patients who were suffering from intraocular choroidal hemangiomas, which involved serious retinal detachments.

Intraocular choroidal hemangiomas are benign tumors, which can cause symptoms due to their location, growth, and the accumulation of fluid in the eye. Doctors generally don't treat the tumors unless the problems lead to vision loss or a detached retina.

In these cases, each of the patients was suffering from a tumor in one eye, and all suffered loss of vision and a detached retina. In the first case, a 60 year old man attempted reatment after experiencing decreased visual acuity in his right eye for two weeks. In the second case, a 40 year old man came to the clinic complaining of flickering lights and decreased visual acuity in his left eye. The third subject was a 65 year old man who had been initially diagnosed in 1995 and followed for the next 5 years, during which time he began to experience significantly worsening vision and an expanding central blind spot.

Researchers used photodynamic therapy to treat the detached retinas and shrink the tumors. Photodynamic therapy includes a light-sensitive dye that produces blood clots to terminate the growth of abnormal new blood vessels. In all three cases, the therapy resolved the detached retinas and shrunk the tumors beyond measurable size. Vision improved to 20/20 for the first two patients and to 20/200 for the third patient. After 10 months to 15 months of follow-up, none of the tumors had returned. Researchers conclude photodynamic therapy appears to be effective for the treatment of choroidal hemangioma.


'"/>




Page: 1

Related medicine news :

1. New Technique For Benign Breast Tumors
2. Another Treatment Option for Benign Tumors
3. ‘Benign’ MS May Not Be So Benin
4. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
5. Morphine may excite cancerous tumors
6. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
7. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Same molecule found in meat, milk, tumors
10. Women with borderline ovarian tumors can still preserve their fertility
11. Surgery to remove tumors in the spine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and Roadie, ... use or need, from clothes to couches to dressers and bicycles. Roadie — the ... to the nearest Goodwill donation center through February 28th. , “January is an ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated ... Institute. For Betsy, the clinical trial has been life-saving as she has been ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in ... where she works in a daycare and looks for inspiration in the local coffee ... Publishing, Sara Seymour’s new book is an adventure of love and secrets. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 The global immunomodulators market is ... according to a new study by Grand View ... predominantly driven by high R&D investments employed by ... of new and therapeutically advanced drugs. This is ... an unprecedented rate into the immunomodulators market hence ...
(Date:1/19/2017)... 2017 Conference Call and Webcast to Follow ... it will release results for the fourth quarter of 2016 on ... ... call at 4:30 PM ET on Wednesday, February 15, 2017, during ... financial results and other corporate activities. To participate in the conference ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
Breaking Medicine Technology: